GlassScriptPhysician profile
Marilyn Milkman
NPI 1477515203
$512.49
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $103 · 2021: $272.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $105.95 | 2021 | |
| Therapeuticsmd, INC. | $64.04 | 2019-2021 | |
| Avion Pharmaceuticals | $51.94 | 2019-2020 | |
| Pfizer INC. | $47.68 | 2021 | |
| Exeltis, USA INC. | $44.88 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $36.66 | 2021 | |
| Gilead Sciences, INC. | $33.49 | 2020 | |
| Ascend Therapeutics US, LLC | $22.85 | 2021 | |
| Coopersurgical, INC. | $20.83 | 2021 | |
| Agile Therapeutics, INC. | $20.79 | 2021 | |
| Amag Pharmaceuticals, INC. | $20.78 | 2020 | |
| Allergan, INC. | $15.39 | 2019 | |
| Merck Sharp & Dohme LLC | $14.96 | 2019 | |
| Amarin Pharma, INC. | $12.25 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marilyn Milkman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.